Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure
- Conditions
- Brain Injuries
- Interventions
- Device: Licox® Brain Tissue Oxygen Monitoring SystemDevice: Near-infrared spectroscopy (NIRS)
- Registration Number
- NCT04247321
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Researchers are trying to assess how accurately and safely NIRS non-invasive monitoring can detect changes in intracranial pressure to determine if this noninvasive device can be used instead of invasive monitoring with Licox in the future.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Subjects with acute brain injury Licox® Brain Tissue Oxygen Monitoring System Subjects requiring placement of a Licox Brain Tissue Oxygen device for their clinical care will also have Near-infrared spectroscopy (NIRS) monitoring system placed Subjects with acute brain injury Near-infrared spectroscopy (NIRS) Subjects requiring placement of a Licox Brain Tissue Oxygen device for their clinical care will also have Near-infrared spectroscopy (NIRS) monitoring system placed
- Primary Outcome Measures
Name Time Method Correlation between changes in Licox and NIRS oxygenation measurements 3 to 5 days of the monitoring duration Licox measures oxygenation in terms of partial pressure (PtO2) and NIRS measures it in terms of saturation (rSO2). The changes in PtO2 versus the changes in rSO2 will be compared for equivalence.
- Secondary Outcome Measures
Name Time Method Correlation between changes in pressure reactivity index and Licox versus NIRS 3 to 5 days of the monitoring duration The pressure reactivity index (PRx) is derived using ICM+ software; the PRx is a correlation coefficient ranging from -1 to +1; PRx \> 0 indicates poor autoregulation. We will investigate if PRx correlates with changes in rSO2 as measured by NIRS (if changes in autoregulation correspond with changes in oxygenation).
Trial Locations
- Locations (1)
Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States